Annovis Bio (NYSE:ANVS) Earns “Hold” Rating from D. Boral Capital
Annovis Bio (NYSE:ANVS – Get Free Report)‘s stock had its “hold” rating reaffirmed by investment analysts at D. Boral Capital in a research report issued on Monday, MarketBeat Ratings reports. Several other analysts have also recently weighed in on ANVS. Maxim Group raised shares of Annovis Bio from a “hold” rating to a “buy” rating […]
Annovis Bio (NYSE:ANVS – Get Free Report)‘s stock had its “hold” rating reaffirmed by investment analysts at D. Boral Capital in a research report issued on Monday, MarketBeat Ratings reports. Several other analysts have also recently weighed in on ANVS. Maxim Group raised shares of Annovis Bio from a “hold” rating to a “buy” rating […]
